China approves first home made anti-HIV drug
Advertisement
BEIJING: China has approved the first domestically developed, long-acting injectable HIV drug Albuvirtide which could be a boon to tens of thousands of HIV/AIDS patients in the country, the official media reported.
The drug, approved by the China Food and Drug Administration, can block the fusion of the virus and host cell membranes, interrupting the HIV life cycle in its earliest stage, state-run Global Times quoted a report from Science and Technology Daily.
Albuvirtide is injected once a week and is secure, a staff from the Nanjing-based Frontier Biotechnologies Inc, surnamed Zhu, told Global Times.
Compared to imported anti-HIV drugs, Albuvirtide has fewer side effects, especially on the liver, state-run Xinhua news agency reported, quoting Wu Hao, head of the infection center at Beijing You' a Hospital.
The drug is a fusion inhibitor that should be used with antiretroviral drugs to treat people with HIV condition who have received antiviral therapy, the company said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.